BenchMark ULTRA
Device Tissue Diagnostics
PDI 04015630981052
General payments
$339,161
Research payments
$3,154,680
Through program year 2025, $339,161 in general payments and $3,154,680 in research payments were reported against BenchMark ULTRA (Tissue Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,160 | 118 |
| 2025 | Research | $6,000 | 10 |
| 2024 | General | $4,940 | 80 |
| 2024 | Research | $245,854 | 25 |
| 2023 | General | $2,661 | 6 |
| 2023 | Research | $206,985 | 38 |
| 2022 | General | $15,074 | 27 |
| 2022 | Research | $640,626 | 74 |
| 2021 | General | $308,326 | 63 |
| 2021 | Research | $2,055,215 | 167 |
Breakdown
The top 5 of 90 recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
294 general · 314 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.